Recent advances in the analysis of nanoparticle-protein coronas
- 1 April 2020
- journal article
- review article
- Published by Future Medicine Ltd in Nanomedicine
- Vol. 15 (10), 1037-1061
- https://doi.org/10.2217/nnm-2019-0381
Abstract
In spite of radical advances in nanobiotechnology, the clinical translation of nanoparticle (NP)-based agents is still a major challenge due to various physiological factors that influence their interactions with biological systems. Recent decade witnessed meticulous investigation on protein corona (PC) that is the first surrounds NPs once administered into the body. Formation of PC around NP surface exhibits resilient effects on their circulation, distribution, therapeutic activity, toxicity and other factors. Although enormous literature is available on the role of PC in altering pharmacokinetics and pharmacodynamics of NPs, understanding on its analytical characterization methods still remains shallow. Therefore, the current review summarizes the impact of PC on biological fate of NPs and stressing on analytical methods employed for studying the NP-PC.Keywords
This publication has 148 references indexed in Scilit:
- Temperature: The “Ignored” Factor at the NanoBio InterfaceACS Nano, 2013
- The use of quartz crystal microbalance with dissipation (QCM-D) for studying nanoparticle-induced platelet aggregationInternational Journal of Nanomedicine, 2012
- Binding of blood proteins to carbon nanotubes reduces cytotoxicityProceedings of the National Academy of Sciences of the United States of America, 2011
- Classification NanoSAR Development for Cytotoxicity of Metal Oxide NanoparticlesSmall, 2011
- Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammationNature Nanotechnology, 2010
- Interaction of colloidal gold nanoparticles with human blood: effects on particle size and analysis of plasma protein binding profilesNanomedicine: Nanotechnology, Biology and Medicine, 2009
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticlesProceedings of the National Academy of Sciences of the United States of America, 2007
- Uncertainty sources in UV-Vis spectrophotometric measurementAccreditation and Quality Assurance, 2006
- How to measure and predict the molar absorption coefficient of a proteinProtein Science, 1995